CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Canadian Journal of Health Technologies

Menu
Begin main content
Home Reports Newborn Male Circumcision for the Prevention of Sexually Transmitted Infections, Urinary Tract Infections, and Cancer: Clinical Effectiveness and Guidelines
Back to Reports

Newborn Male Circumcision for the Prevention of Sexually Transmitted Infections, Urinary Tract Infections, and Cancer: Clinical Effectiveness and Guidelines

Last updated: February 6, 2015
Project Number: RB0785-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of newborn male circumcision for the prevention of sexually transmitted infections (STIs), urinary tract infections (UTIs), and cancer?
  2. What are the evidence-based guidelines regarding the medical indications for newborn male circumcisions?

Key Message

Seven systematic reviews and 16 non-randomized studies were identified regarding the clinical effectiveness of newborn male circumcision for the prevention of STIs, UTIs, and cancer. In addition, three evidence-based guidelines were identified regarding the medical indications for newborn male circumcisions.

Files

Newborn Male Circumcision for the Prevention of Sexually Transmitted Infections, Urinary Tract Infections, and Cancer: Clinical Effectiveness and Guidelines

Rapid Response

Summary of Abstracts

  • Published: February 6, 2015